Comment. Monday 25 October 2010
Monday, October 25th, 2010Just a couple of thoughts ahead of the upcoming Novogen and MEI annual meetings. The first is in relation to the Sept 8 announcement concerning the sale of the isoflavonoid technology from Novogen to MEI. I was expecting some mention of it in the Notice of Meeting of the Novogen AGM. Whether they have struck [...]